AU2007344604A1 - A forsythiaside injection and preparation thereof - Google Patents

A forsythiaside injection and preparation thereof Download PDF

Info

Publication number
AU2007344604A1
AU2007344604A1 AU2007344604A AU2007344604A AU2007344604A1 AU 2007344604 A1 AU2007344604 A1 AU 2007344604A1 AU 2007344604 A AU2007344604 A AU 2007344604A AU 2007344604 A AU2007344604 A AU 2007344604A AU 2007344604 A1 AU2007344604 A1 AU 2007344604A1
Authority
AU
Australia
Prior art keywords
forsythiaside
injection
weight
water
stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007344604A
Other languages
English (en)
Inventor
Guojun Chen
Xiaochun Huang
Hongguo Lu
Tianjiang Sun
Qiuling Tang
Yong Wang
Zhenyu Xuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong New Time Pharmaceutical Co Ltd
Original Assignee
Shandong New Time Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong New Time Pharmaceutical Co Ltd filed Critical Shandong New Time Pharmaceutical Co Ltd
Publication of AU2007344604A1 publication Critical patent/AU2007344604A1/en
Assigned to SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. reassignment SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. Request for Assignment Assignors: SHANGHAI YOUSEEN NEW MEDICINE EXPLOITION CO., LTD., YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2007344604A 2006-12-28 2007-12-24 A forsythiaside injection and preparation thereof Abandoned AU2007344604A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200610148180 2006-12-28
CN200610148180.3 2006-12-28
PCT/CN2007/003757 WO2008086698A1 (en) 2006-12-28 2007-12-24 A forsythoside injection and preparation thereof

Publications (1)

Publication Number Publication Date
AU2007344604A1 true AU2007344604A1 (en) 2008-07-24

Family

ID=39609619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007344604A Abandoned AU2007344604A1 (en) 2006-12-28 2007-12-24 A forsythiaside injection and preparation thereof

Country Status (7)

Country Link
US (1) US20100317604A1 (cg-RX-API-DMAC7.html)
EP (1) EP2113252A4 (cg-RX-API-DMAC7.html)
JP (1) JP5546867B2 (cg-RX-API-DMAC7.html)
KR (1) KR101117861B1 (cg-RX-API-DMAC7.html)
CN (1) CN101209255B (cg-RX-API-DMAC7.html)
AU (1) AU2007344604A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008086698A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101919869B (zh) * 2009-06-16 2013-06-05 上海医药工业研究院 一种连翘酯苷a药物组合物
CN103054884B (zh) * 2011-10-18 2015-11-04 鲁南制药集团股份有限公司 连翘酯苷在制备抗副流感病毒药物中的用途及其制剂
CN103054885A (zh) * 2011-10-18 2013-04-24 鲁南制药集团股份有限公司 连翘酯苷在制备抗甲型h1n1病毒药物中的用途及其制剂
CN102512371A (zh) * 2012-01-09 2012-06-27 北京农学院 一种连翘酯苷脂质体的制备方法
KR102201194B1 (ko) * 2013-11-18 2021-01-12 주식회사 엘지생활건강 피부 재생, 주름 개선, 항염증 또는 피부 미백용 조성물
CN105168372A (zh) * 2015-10-16 2015-12-23 山西大学 连翘叶或其组分在制备减肥制品中的应用
CN112946113B (zh) * 2021-02-01 2022-09-30 湖北医药学院 一种鉴别道地药材十堰连翘基源的方法
CN114990054B (zh) * 2022-07-22 2023-07-21 成都艾伟孚生物科技有限公司 一种辅助生殖用洗精受精液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1032876C (zh) * 1991-08-12 1996-09-25 兖州矿务局科研所 高潜水塌陷区抗变形可搬迁房屋
US6083921A (en) * 1998-01-12 2000-07-04 Xu; Kai Jian Pharmaceutical compositions and method of using same
JP3882106B2 (ja) * 2000-12-06 2007-02-14 三栄源エフ・エフ・アイ株式会社 退色抑制剤
US6953786B2 (en) * 2002-10-01 2005-10-11 The Regents Of The University Of California Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
JP2006188436A (ja) * 2004-12-28 2006-07-20 Japan Science & Technology Agency 医用ポリフェノール溶液

Also Published As

Publication number Publication date
JP2010514706A (ja) 2010-05-06
EP2113252A4 (en) 2012-10-31
WO2008086698A1 (en) 2008-07-24
CN101209255A (zh) 2008-07-02
US20100317604A1 (en) 2010-12-16
KR101117861B1 (ko) 2012-03-14
KR20090095668A (ko) 2009-09-09
EP2113252A1 (en) 2009-11-04
JP5546867B2 (ja) 2014-07-09
CN101209255B (zh) 2013-04-03

Similar Documents

Publication Publication Date Title
AU2007344604A1 (en) A forsythiaside injection and preparation thereof
US5716631A (en) Long acting narcotic analgesics and antagonists
JP2010514706A5 (cg-RX-API-DMAC7.html)
CN102885348B (zh) 一种具有补肾作用的杞椹饮料及其制备方法
DE69031694T3 (de) Glutamin zur Behandlung von beeinträchtigten Abwehrkräften
WO2010075611A1 (en) Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance
CN112891363B (zh) 新西兰牡荆苷2与新西兰牡荆苷3的用途
CN105535951A (zh) 一种乌司他丁注射液及其制备方法
CN101703466A (zh) 冰片注射剂及其制剂方法
CN101810666B (zh) 兽用增效恩诺沙星注射液及其制备方法
CN100396289C (zh) 灯盏花乙素注射制剂及其制备方法
CN101212963B (zh) 绿原酸在制备具有增加骨髓细胞功效的药物中的用途
CN106974927A (zh) 金丝桃苷用于制备预防和治疗酒精性肝病药物或保健品中的应用
CN111920835A (zh) 一种药物制剂在制备治疗老年痴呆的药物中的应用
JP3913795B2 (ja) 安定な解熱鎮痛剤配合液剤
RU2197257C2 (ru) Лекарственное средство "фитобальзам - фабацерон" для иммунокоррекции с седативным действием
CN110179860A (zh) 一种抗癫痫的药物、其制备方法及用途
CN107569475A (zh) 一种具有改善血液循环功效的药物组合物及其应用和由其制备形成的注射剂
EP1309353B1 (de) Flavonhaltige pflanzenextraktlösungen mit verbesserter lager- und hitzestabilität
CN107823130A (zh) 一种汉防己碱注射制剂药物组合物的制备方法
CN107308235A (zh) 一种防治鸡球虫病的中药组合物以及制备方法
CN1128155C (zh) 一种槲寄生糖蛋白提取物及含有该提取物的药物组合物及其制备方法
CN100506235C (zh) 一种治疗脑血管疾病的冻干制剂
KR20250096548A (ko) 톳 후코이단을 유효성분으로 함유하는 면역기능 조절 및 염증성 장질환의 예방, 개선 및 치료용 조성물
RU2409380C1 (ru) Способ получения иммуностимулирующего препарата для животных и иммуностимулирующий препарат на его основе

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.

Free format text: FORMER APPLICANT(S): YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD.; SHANGHAI YOUSEEN NEW MEDICINE EXPLOITION CO., LTD.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ A FORSYTHIASIDE INJECTION AND PREPARATION THEREOF

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application